Coffee and the Heart: What Large Studies Can—and Cannot—Tell Us

A 2022 UK Biobank analysis followed nearly 450,000 participants and reported lower observed rates of several cardiovascular outcomes among some coffee-drinking groups. Because this was observational research, it cannot show that coffee caused the difference.

Results varied by coffee type and participant group. Self-reported intake, residual confounding, and selection effects are important limits when translating cohort findings into personal decisions.

A separate 2024 paper in the American Journal of Clinical Nutrition zeroed in on chlorogenic acids, a class of antioxidants abundant in lightly roasted beans. Subjects who drank three cups of high-chlorogenic-acid coffee daily for eight weeks showed measurable improvements in flow-mediated dilation — a direct measure of how responsive blood vessels are — comparable to those seen with a Mediterranean-diet intervention.

Short controlled studies can measure intermediate markers, but they do not by themselves establish fewer heart attacks or strokes. A biomarker result is not a product-level health claim.

Personal advice depends on blood pressure, rhythm conditions, medications, pregnancy, sleep, and caffeine sensitivity. People with cardiovascular concerns should discuss intake with their clinician rather than treating a population study as a prescription.